Bliss GVS Pharma Limited (NSE:BLISSGVS)
India
· Delayed Price · Currency is INR 116.42
-2.19 (-1.85%)
Mar 12, 2025, 3:29 PM IST
Bliss GVS Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | - | 754.54 | 708.59 | 150.4 | 684.91 | 972.65 | Upgrade
|
| Depreciation & Amortization | - | 262.57 | 185.13 | 171.33 | 170.27 | 123.63 | Upgrade
|
| Other Amortization | - | 1.23 | 1.61 | 1.98 | 2.03 | 2.26 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -2.86 | -3.65 | -1.38 | 0.31 | -3.6 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | - | - | - | 133.81 | Upgrade
|
| Stock-Based Compensation | - | 38.16 | 39.04 | 57.08 | 98.38 | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | 252.74 | 228.07 | 227.8 | 39.57 | 54.35 | Upgrade
|
| Other Operating Activities | - | 187.7 | 35.54 | 13.87 | 223.09 | -112.86 | Upgrade
|
| Change in Accounts Receivable | - | -445.19 | -149.98 | 512.91 | 629.26 | -785.31 | Upgrade
|
| Change in Inventory | - | -224.22 | 150.03 | -290.97 | -268.01 | 8.06 | Upgrade
|
| Change in Accounts Payable | - | -251 | -63.16 | 183.44 | -146.76 | 128.41 | Upgrade
|
| Change in Other Net Operating Assets | - | 950.82 | -788.08 | 328.34 | -793.35 | -54.37 | Upgrade
|
| Operating Cash Flow | - | 1,524 | 343.14 | 1,355 | 639.69 | 467.02 | Upgrade
|
| Operating Cash Flow Growth | - | 344.28% | -74.67% | 111.79% | 36.97% | 16.90% | Upgrade
|
| Capital Expenditures | - | -283.29 | -937.99 | -740.03 | -91.24 | -592.6 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 6.03 | 6.91 | 10.68 | 4.21 | 8.56 | Upgrade
|
| Investment in Securities | - | 43.41 | -54.58 | -22.31 | -436.89 | 23.66 | Upgrade
|
| Other Investing Activities | - | -1,094 | 908.15 | -178.09 | 53.87 | 80.98 | Upgrade
|
| Investing Cash Flow | - | -1,328 | -77.51 | -929.75 | -469.91 | -478.94 | Upgrade
|
| Long-Term Debt Issued | - | 154.88 | 400.22 | 107.56 | 96.65 | 284.09 | Upgrade
|
| Long-Term Debt Repaid | - | -272.36 | -552.68 | -284.81 | -185.94 | -173.31 | Upgrade
|
| Net Debt Issued (Repaid) | - | -117.48 | -152.46 | -177.26 | -89.29 | 110.78 | Upgrade
|
| Issuance of Common Stock | - | 23.5 | 20.42 | 22.84 | - | - | Upgrade
|
| Common Dividends Paid | - | -53.95 | -54.37 | -53.27 | -55.5 | -125 | Upgrade
|
| Other Financing Activities | - | -61 | -62.97 | -29.62 | -63.2 | -48.82 | Upgrade
|
| Financing Cash Flow | - | -208.93 | -249.39 | -237.3 | -207.98 | -63.05 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -1.5 | 13.96 | -99.23 | 16.15 | 77.47 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | - | 0.53 | Upgrade
|
| Net Cash Flow | - | -14.16 | 30.2 | 88.53 | -22.05 | 3.03 | Upgrade
|
| Free Cash Flow | - | 1,241 | -594.86 | 614.78 | 548.45 | -125.58 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 12.09% | - | - | Upgrade
|
| Free Cash Flow Margin | - | 16.11% | -7.91% | 8.22% | 9.50% | -1.82% | Upgrade
|
| Free Cash Flow Per Share | - | 11.70 | -5.64 | 5.84 | 5.20 | -1.22 | Upgrade
|
| Cash Interest Paid | - | 61 | 62.97 | 29.62 | 63.2 | 48.3 | Upgrade
|
| Cash Income Tax Paid | - | 348.51 | 445.55 | 339.43 | 285.63 | 387.92 | Upgrade
|
| Levered Free Cash Flow | - | 35.75 | -184.61 | 1,059 | 691.96 | -979.14 | Upgrade
|
| Unlevered Free Cash Flow | - | 73.57 | -122.96 | 1,082 | 718.84 | -936.03 | Upgrade
|
| Change in Net Working Capital | - | 721.61 | 27.3 | -958.58 | 19.63 | 1,164 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.